Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |